Nick Leschly
2016 - bluebird bio
Compensation breakdown
Non-Equity Incentive Plan | $309,375 |
---|---|
Option Awards | $2,929,487 |
Salary | $500,000 |
Stock Awards | $1,136,475 |
Other | $5,250 |
Total | $4,880,587 |
Leschly received $2.9M in option awards, accounting for 60% of the total pay in 2016.
Leschly also received $309.4K in non-equity incentive plan, $500K in salary, $1.1M in stock awards and $5.3K in other compensation.
Rankings
In 2016, Nick Leschly's compensation ranked 1,672nd out of 14,075 executives tracked by ExecPay. In other words, Leschly earned more than 88.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,672 | 88th |
Manufacturing | 566 | 90th |
Chemicals And Allied Products | 160 | 92nd |
Drugs | 109 | 93rd |
Biological Products, Except Diagnostic Substances | 21 | 93rd |
Leschly's colleagues
We found six more compensation records of executives who worked with Nick Leschly at bluebird bio in 2016.
2016
Susanna High
bluebird bio
Chief Operating Officer
2016
Jeffrey Walsh
bluebird bio
Chief Financial and Strategy Officer
2016
David Davidson
bluebird bio
Chief Medical Officer
2016
Philip Gregory
bluebird bio
Chief Scientific Officer
2016
Jason Cole
bluebird bio
Chief Legal Officer
2016
James DeTore
bluebird bio
Chief Financial Officer
News
April 25, 2024
May 2, 2022
April 26, 2022
April 27, 2020
April 23, 2019